Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.92
+0.64 (12.12%)
Feb 24, 2026, 4:00 PM EST - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $192.53 million as of February 25, 2026. Its market cap has increased by 26.96% in one year.
Market Cap
192.53M
Enterprise Value
67.14M
1-Year Change
26.96%
Ranking
Category
Stock Price
$5.92
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $192.53M, a decrease of -45.74%. That is a compound annual growth rate of -20.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 171.71M | -10.81% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 200.02M |
| Heron Therapeutics | 199.87M |
| Ovid Therapeutics | 196.58M |
| Cartesian Therapeutics | 196.33M |
| Eledon Pharmaceuticals | 194.41M |
| NeOnc Technologies Holdings | 188.90M |
| Fate Therapeutics | 186.87M |
| Canton Strategic Holdings | 186.19M |